Table 2 Drug treatments used in this... | American Society of Hematology

Table 2

Drug treatments used in this study

Drug	Provider	Concentration used (range)	Pretreatment of effector cells	Figures in current paper
Latrunculin B	Calbiochem	25 μM (1-300 μM)	2 h	1,2,4,5
PP2	Calbiochem	10 μM (0.1-100 μM)	20 min	1,2,4,S1
Cytochalasin D	Sigma-Aldrich	10 μM	2 h	1,4
Nocodazole	Sigma-Aldrich	100 nM	2 h	1
Piceatannol	Calbiochem	100 μM	20 min	1
Wortmannin	Sigma-Aldrich	100 nM	20 min	1
EDTA	Sigma-Aldrich	2 mM	None	2,4

Drug	Provider	Concentration used (range)	Pretreatment of effector cells	Figures in current paper
Latrunculin B	Calbiochem	25 μM (1-300 μM)	2 h	1,2,4,5
PP2	Calbiochem	10 μM (0.1-100 μM)	20 min	1,2,4,S1
Cytochalasin D	Sigma-Aldrich	10 μM	2 h	1,4
Nocodazole	Sigma-Aldrich	100 nM	2 h	1
Piceatannol	Calbiochem	100 μM	20 min	1
Wortmannin	Sigma-Aldrich	100 nM	20 min	1
EDTA	Sigma-Aldrich	2 mM	None	2,4

Calbiochem (San Diego, CA); Sigma-Aldrich (St Louis, MO).